Andrew Bottomley
About
Andrew Bottomley is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Economics and Econometrics.
According to data from OpenAlex, Andrew Bottomley has authored 48 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 8 papers in Economics and Econometrics. Recurrent topics in Andrew Bottomley's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Brain Metastases and Treatment (5 papers). Andrew Bottomley is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Brain Metastases and Treatment (5 papers). Andrew Bottomley collaborates with scholars based in Belgium, Netherlands and United Kingdom. Andrew Bottomley's co-authors include Michael Koller, Jan P. van Meerbeeck, Neil Scott, Neil K. Aaronson, Giuseppe Giaccone, Catherine Legrand, Jane Blazeby, L. Claassens, C. Debruyne and Rabab Gaafar and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.
In The Last Decade
Andrew Bottomley
46 papers receiving 3.3k citations
Hit Papers
Peers
Andrew Bottomley
Peter A.S. Johnstone United States
Elizabeth Barnes Canada
Yolanda I. Garces United States
Joanne F. Chou United States
James D. Murphy United States
Jürg Bernhard Switzerland
Kim Cocks United Kingdom
James D. Bearden United States
Clement Ma United States
Ayal A. Aizer United States
Citations per year, relative to Andrew Bottomley Andrew Bottomley (= 1×)
peers
Peter A.S. Johnstone
Countries citing papers authored by Andrew Bottomley
Since
Specialization
Citations
This map shows the geographic impact of Andrew Bottomley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Bottomley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Bottomley more than expected).
Fields of papers citing papers by Andrew Bottomley
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Andrew Bottomley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Bottomley. The network helps show where Andrew Bottomley may publish in the future.
Co-authorship network of co-authors of Andrew Bottomley
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Bottomley. A scholar is included among the top collaborators of Andrew Bottomley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Bottomley. Andrew Bottomley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Barman, Sarah, et al.. (2025). FK506 binding protein like, FKBPL, as a novel therapeutic target in 2D and 3D bioprinted, models of cardiac fibrosis. Bioprinting. 47. e00397–e00397.
2.
Oosting, Sjoukje F., Jorge Barriuso, Andrew Bottomley, et al.. (2022). Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit. Annals of Oncology. 34(4). 431–439.
3.
Lehmann, Jens, et al.. (2021). Functional health and symptoms in Spain before and during the COVID-19 pandemic. BMC Public Health. 21(1). 837–837.
4.
Hamel, Jean‐François, Madeline Pe, Corneel Coens, et al.. (2016). A systematic review examining factors influencing health related quality of life among melanoma cancer survivors. European Journal of Cancer. 69. 189–198.
5.
Zikos, Efstathios, Irina Ghislain, Corneel Coens, et al.. (2014). Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trials. The Lancet Oncology. 15(2). e78–e89.
6.
Henriksson, Roger, Andrew Bottomley, Warren Mason, et al.. (2013). Progression-free survival (PFS) and health-related quality of life (HRQoL) in AVAglio, a phase III study of bevacizumab (Bv), temozolomide (T), and radiotherapy (RT) in newly diagnosed glioblastoma (GBM).. Journal of Clinical Oncology. 31(15_suppl). 2005–2005.
7.
Dirven, Linda, J.C. Reijneveld, Neil K. Aaronson, et al.. (2013). Health-related Quality of Life in Patients with Brain Tumors: Limitations and Additional Outcome Measures. Current Neurology and Neuroscience Reports. 13(7). 359–359.
8.
Soffietti, Riccardo, Martin Köcher, Ufuk Abacıoğlu, et al.. (2012). A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results. Journal of Clinical Oncology. 31(1). 65–72.
9.
Herpen, Carla M.L. van, Murielle Mauer, Ricard Mesı́a, et al.. (2010). Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323). British Journal of Cancer. 103(8). 1173–1181.
10.
Scott, Neil, Peter Fayers, Neil K. Aaronson, et al.. (2009). The practical impact of differential item functioning analyses in a health-related quality of life instrument. Quality of Life Research. 18(8). 1125–1130.
11.
Slotman, Ben J., Murielle Mauer, Andrew Bottomley, et al.. (2008). Prophylactic Cranial Irradiation in Extensive Disease Small-Cell Lung Cancer: Short-Term Health-Related Quality of Life and Patient Reported Symptoms—Results of an International Phase III Randomized Controlled Trial by the EORTC Radiation Oncology and Lung Cancer Groups. Journal of Clinical Oncology. 27(1). 78–84.
12.
Scott, Neil, Peter Fayers, Neil K. Aaronson, et al.. (2008). A simulation study provided sample size guidance for differential item functioning (DIF) studies using short scales. Journal of Clinical Epidemiology. 62(3). 288–295.
13.
Bottomley, Andrew. (2008). The journey of health-related quality of life assessment. The Lancet Oncology. 9(9). 906–906.
14.
Bottomley, Andrew, et al.. (2008). Patient-reported outcomes: Assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. European Journal of Cancer. 45(3). 347–353.
15.
Bottomley, Andrew & Neil K. Aaronson. (2007). International Perspective on Health-Related Quality-of-Life Research in Cancer Clinical Trials: The European Organisation for Research and Treatment of Cancer Experience. Journal of Clinical Oncology. 25(32). 5082–5086.
16.
Efficace, Fabio, Andrew Bottomley, Egbert F. Smit, et al.. (2006). Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Annals of Oncology. 17(11). 1698–1704.
17.
Efficace, Fabio, Andrew Bottomley, Veerle Vanvoorden, & Jane Blazeby. (2003). Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials. European Journal of Cancer. 40(2). 187–197.
18.
Blazeby, Jane, Thierry Conroy, Eva Hammerlid, et al.. (2003). Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. European Journal of Cancer. 39(10). 1384–1394.
19.
Bottomley, Andrew, Peter Fayers, Alexander de Graeff, et al.. (2001). Psychometric properties of the EORTC quality of life core questionnaire (QLQ-C30) in EORTC trials. European Journal of Cancer. 37. S351–S352.
20.
Bottomley, Andrew & Lynn Jones. (1997). Breast cancer care: women's experience. European Journal of Cancer Care. 6(2). 124–132.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Peter A.S. Johnstone Breakdown of academic impact, for papers by Elizabeth Barnes Breakdown of academic impact, for papers by Yolanda I. Garces Breakdown of academic impact, for papers by Joanne F. Chou Breakdown of academic impact, for papers by James D. Murphy Breakdown of academic impact, for papers by Jürg Bernhard Breakdown of academic impact, for papers by Kim Cocks Breakdown of academic impact, for papers by James D. Bearden Breakdown of academic impact, for papers by Clement Ma Breakdown of academic impact, for papers by Ayal A. Aizer